People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Other Technology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Actifio, Inc. | — | Other Technology | Series C | $237.5M | $1.9B | 2018 |
| Bio Key International Inc | — | Biotech / Pharma | Series A | $16.7M | $3.7M | 2023 |
Jim Sullivan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jim Sullivan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Levine | 1 | 11 |
| Erez Ofer | 1 | 7 |
| Robert Hower | 1 | 7 |
| James Goldstein | 1 | 6 |
| David Chang | 1 | 6 |
| Jitendra Saxena | 1 | 6 |
| Jit Saxena | 1 | 5 |
| RICHARD KIMBALL | 1 | 5 |
| Bob Hower | 1 | 5 |
| Cameron Williams | 1 | 4 |
| David Dyer | 1 | 3 |
| James A. Goldstein | 1 | 3 |
| Bill Burgess | 1 | 3 |
| Rick Kimball | 1 | 2 |
| Edward Durkin | 1 | 2 |
| Peter A. Levine | 1 | 2 |
| Robert A. Hower | 1 | 2 |
| Cecilia C. Welch | 1 | 1 |
| Thomas J. Colatosti | 1 | 1 |
| Michael W. DePasquale | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.